NSPR has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NSPR has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
InspireMD's other long-term assets for the quarter that ended in Sep. 2024 was $1.00 Mil.
InspireMD's quarterly other long-term assets declined from Mar. 2024 ($0.96 Mil) to Jun. 2024 ($0.96 Mil) but then increased from Jun. 2024 ($0.96 Mil) to Sep. 2024 ($1.00 Mil).
InspireMD's annual other long-term assets declined from Dec. 2021 ($0.91 Mil) to Dec. 2022 ($0.86 Mil) but then increased from Dec. 2022 ($0.86 Mil) to Dec. 2023 ($0.95 Mil).
The historical data trend for InspireMD's Other Long Term Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
InspireMD Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Other Long Term Assets | Get a 7-Day Free Trial | 0.59 | 0.73 | 0.91 | 0.86 | 0.95 |
InspireMD Quarterly Data | ||||||||||||||||||||
Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | |
Other Long Term Assets | Get a 7-Day Free Trial | 0.85 | 0.95 | 0.96 | 0.96 | 1.00 |
GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.
Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.
Gary S Roubin | director | 4300 ROCKMORE RD JACKSON, WYOMING WY 83001 |
Patrick Verta | officer: EVP Clinical/Medical Affairs | 12988 VALLEY VIEW ROAD, EDEN PRAIRIE MN 55344 |
Michael Berman | director | 735 PALAMAR AVENUE, SUNNYVALE CA 94085 |
Thomas J Kester | director | C/O INSPIREMD, INC., 321 COLUMBUS AVENUE, BOSTON MA 02116 |
Paul Stuka | director | C/O OSIRIS PARTNERS, LLC, ONE LIBERTY SQUARE, 5TH FLOOR, BOSTON MA 02109 |
Andrea Tommasoli | officer: Chief Operating Officer | 22, RUE DE LA PLAGE, COLLONGES AU MONT D OR I0 69660 |
Shane Thomas Gleason | officer: VP Global Marketing | 18 NORTHAMPTON PL, COTO DE CAZA CA 92679 |
Kathryn Arnold | director | 1136 CHESTNUT AVE., WILMETTE IL 60091 |
Marvin Slosman | director, officer: CEO and President | 4 MENORAT HAMAOR ST., C/O INSPIREMD, INC., TEL AVIV L3 6744832 |
Isaac Blech | director | C/O INSPIREMD, INC., 321 COLUMBUS AVENUE, BOSTON MA 02116 |
Agustin V Gago | officer: EVP, Chief Commercial Officer | 256 JERUSALEM AVE, MASSAPEQUA NY 11758 |
Eric L. Olson | officer: VP of Global Sales Operations | C/O INSPIREMD, INC., 800 BOYLSTON STREET, 16TH FLOOR, BOSTON MA 02199 |
Campbell Rogers | director | C/O INSPIREMD, INC., 800 BOYLSTON STREET, SUITE 16041, BOSTON MA 02199 |
James J Barry | director | C/O INSPIREMD, INC., 4 MENORAT HAMAOR ST., TEL AVIV L3 6744832 |
Eyal Weinstein | director | C/O LEOREX LTD., P.O.B. 15067 MATAM, HAIFA L3 31905 |
From GuruFocus
By Marketwired • 07-01-2024
By GuruFocus News • 10-09-2024
By GlobeNewswire • 11-08-2024
By Marketwired • 07-30-2024
By Marketwired • 11-12-2024
By GuruFocus News • 10-28-2024
By Marketwired • 08-05-2024
By GuruFocus Research • 02-08-2024
By Marketwired • 11-08-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.